CY1108505T1 - Σκευασματα κολικου καθαρισμου - Google Patents

Σκευασματα κολικου καθαρισμου

Info

Publication number
CY1108505T1
CY1108505T1 CY20081101293T CY081101293T CY1108505T1 CY 1108505 T1 CY1108505 T1 CY 1108505T1 CY 20081101293 T CY20081101293 T CY 20081101293T CY 081101293 T CY081101293 T CY 081101293T CY 1108505 T1 CY1108505 T1 CY 1108505T1
Authority
CY
Cyprus
Prior art keywords
ascorbic acid
sodium phosphate
sodium
based formulations
better
Prior art date
Application number
CY20081101293T
Other languages
English (en)
Inventor
Norman Barras
Ian David Cox
Alex Ungar
Marc Halphen
Original Assignee
Norgine B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9946609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108505(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norgine B.V. filed Critical Norgine B.V.
Publication of CY1108505T1 publication Critical patent/CY1108505T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ένα σκεύασμα που περιέχει, ανά λίτρο υδατικού διαλύματος, από 30 ως 350 g πολυαιθυλενογλυκόλης, από 3 ως 20 g ενός συστατικού ασκορβικού οξέος που επιλέγεται από την ομάδα που περιλαμβάνει ασκορβικό οξύ, ένα άλας ασκορβικού οξέος, ή ένα μίγμα αυτών, ένα θειικό άλας αλκαλιμετάλλου ή αλκαλικής γαίας, κατά προτίμηση 1 ως 15 g αυτού, και προαιρετικώς έναν ή περισσότερους ηλεκτρολύτες που επιλέγονται από χλωριούχο νάτριο, χλωριούχο κάλιο, και όξινο ανθρακικό νάτριο, και κατά προτίμηση επίσης βελτιωτικά γεύσης, είναι αποτελεσματικό για τον καθαρισμό του εντέρου κατά την προετοιμασία για ενδοσκοπική εξέταση, και ιδιαίτερα κολονοσκόπηση. Είναι ασφαλέστερο από συμβατικά σκευάσματα καθαρισμού του εντέρου που βασίζονται σε φωσφορικό νάτριο, και συνεπώς μπορεί να χρησιμοποιηθεί σε ασθενείς που κινδυνεύουν με σκευάσματα που βασίζονται σε φωσφορικό νάτριο, και είναι καλύτερα ανεκτό από συμβατικά σκευάσματα που βασίζονται σε PEG, πράγμα που οδηγεί σε καλύτερη συμμόρφωση ασθενών και καθιστά δυνατή την αποτελεσματική χρήση σε εξωτερικούς ασθενείς.
CY20081101293T 2002-10-25 2008-11-12 Σκευασματα κολικου καθαρισμου CY1108505T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0224909.2A GB0224909D0 (en) 2002-10-25 2002-10-25 Colon cleansing compositions
EP03758361A EP1567193B1 (en) 2002-10-25 2003-10-24 Colon cleansing compositions

Publications (1)

Publication Number Publication Date
CY1108505T1 true CY1108505T1 (el) 2014-04-09

Family

ID=9946609

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20081101293T CY1108505T1 (el) 2002-10-25 2008-11-12 Σκευασματα κολικου καθαρισμου
CY20131100308T CY1113933T1 (el) 2002-10-25 2013-04-12 Σκευασματα κολικου καθαρισμου
CY20191100829T CY1121977T1 (el) 2002-10-25 2019-08-05 Συνθεσεις καθαρισμου του κολον

Family Applications After (2)

Application Number Title Priority Date Filing Date
CY20131100308T CY1113933T1 (el) 2002-10-25 2013-04-12 Σκευασματα κολικου καθαρισμου
CY20191100829T CY1121977T1 (el) 2002-10-25 2019-08-05 Συνθεσεις καθαρισμου του κολον

Country Status (23)

Country Link
US (8) US7169381B2 (el)
EP (3) EP2014304B9 (el)
JP (3) JP4131266B2 (el)
CN (2) CN101897721B (el)
AT (1) ATE404223T1 (el)
AU (3) AU2003274377B2 (el)
CA (2) CA2502103C (el)
CY (3) CY1108505T1 (el)
DE (4) DE20321510U1 (el)
DK (3) DK2014304T3 (el)
ES (3) ES2739387T3 (el)
GB (1) GB0224909D0 (el)
HK (2) HK1077196A1 (el)
HU (1) HUE045881T2 (el)
LT (1) LT2314319T (el)
MX (1) MXPA05004347A (el)
PL (2) PL216059B1 (el)
PT (3) PT1567193E (el)
RU (3) RU2519562C9 (el)
SI (3) SI1567193T1 (el)
TR (1) TR201909741T4 (el)
WO (1) WO2004037292A1 (el)
ZA (1) ZA200503247B (el)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
JP2005187448A (ja) * 2004-04-02 2005-07-14 Ajinomoto Co Inc 腸管洗浄用組成物
BRPI0510004A (pt) * 2004-04-20 2007-09-18 Univ Chicago artigo de manufatura, métodos para administrar uma composição terapêutica a um epitélio de um indivìduo, para tratar uma condição mediada por micróbio de um epitélio de um indivìduo, para melhorar um sintoma de uma condição e para prevenir uma condição, e, uso de composto tipo peg pma
US20060051428A1 (en) * 2004-09-03 2006-03-09 Nelson Ayala Aspartame and citrate flavored phosphate salt laxative
GB2471037A (en) * 2005-10-07 2010-12-15 Cb Fleet Co Inc Bowel cleansing composition comprising sweeteners
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
ES2278537B1 (es) * 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
CN101804068B (zh) * 2006-03-06 2012-05-02 桑苏君 聚乙二醇-电解质口服溶液
CN1850112B (zh) * 2006-03-06 2011-06-29 北京圣永制药有限公司 聚乙二醇-电解质口服溶液
GB0608433D0 (en) * 2006-04-28 2006-06-07 Obrist Closures Switzerland Closure with RFID device
CN100389779C (zh) * 2006-07-07 2008-05-28 北京昭衍博纳新药研究有限公司 一种用于肠道清洁的药物组合物
US7998510B2 (en) * 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
US20090053304A1 (en) * 2007-08-23 2009-02-26 Jinling Chen Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy
US20100297264A1 (en) * 2007-10-17 2010-11-25 Thomas Jefferson University Bowel purgative and uses thereof
ES2509892T3 (es) * 2008-05-07 2014-10-20 Salix Pharmaceuticals, Ltd. Administración de un agente para limpieza del intestino y antibiótico para el tratamiento de enfermedad intestinal
US20100178360A1 (en) * 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
DK2421373T3 (da) * 2009-04-21 2019-12-16 Dale R Bachwich Tarmrensningssystem
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
IT1404366B1 (it) 2009-07-17 2013-11-22 Norgine Bv Composizioni perfezionate per la pulizia del colon
AU2011101324B4 (en) * 2009-07-17 2012-01-19 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
ES2409842T3 (es) 2009-11-02 2013-06-28 Promefarm S.R.L. Composiciones para la limpieza intestinal y uso de las mismas
CA2792647A1 (en) * 2010-03-10 2011-09-15 Nogra Pharma Limited Compositions for colon lavage and methods of making and using same
EP2564875A4 (en) 2010-04-30 2016-03-30 Ajinomoto Kk LIQUID PREPARATION FOR ORAL ADMINISTRATION THAT CAN BE USED IN CT COLONOGRAPHY, AND COMPOSITION FOR DIGESTIVE TRACT IMAGING
CN102232969B (zh) * 2010-05-07 2012-12-19 重庆健能医药开发有限公司 一种磷酸钠盐组合物
ES2951828T3 (es) 2010-09-23 2023-10-25 Leading Biosciences Inc Administración de inhibidores de serina proteasa al estómago
JP5910501B2 (ja) 2010-10-08 2016-04-27 味の素株式会社 Ｃｔコロノグラフィに用いられる経口投与用液剤及び消化管造影用組成物
JP5870119B2 (ja) 2011-01-28 2016-02-24 ブレインツリー ラボラトリーズ、インク． 腸洗浄のための、方法、組成物、およびパッケージ
EA201300864A1 (ru) 2011-01-31 2013-12-30 Адзиномото Ко., Инк. Многокамерный контейнер
GB201103942D0 (en) * 2011-03-08 2011-04-20 Norgine Bv Compositions
TWI535461B (zh) * 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
JP5708141B2 (ja) * 2011-03-30 2015-04-30 味の素株式会社 経口投与用液剤を調製するための経口投与用製剤
CN108904439A (zh) * 2011-12-07 2018-11-30 Msm创新有限公司 味道修饰物质用于修饰胃肠道准备组合物味道的用途
US20190314450A1 (en) * 2011-12-07 2019-10-17 Msm Innovations, Inc. Method and kit for bowel preparation
KR101210831B1 (ko) 2012-02-10 2012-12-11 주식회사태준제약 폴리에틸렌글리콜과 비타민 씨를 함유하는 장관 하제 조성물
CN103520202B (zh) * 2012-07-02 2015-09-02 舒泰神（北京）生物制药股份有限公司 用于通便和清肠的药物组合物
CN109260455A (zh) * 2012-08-03 2019-01-25 Msm创新有限公司 矫味试剂盒
CN102805753B (zh) * 2012-08-20 2014-09-24 深圳万和制药有限公司 包含聚乙二醇和电解质的药物组合物
CN102805752B (zh) * 2012-08-20 2014-04-02 深圳万和制药有限公司 复方聚乙二醇电解质散及其制备方法
CN102772427B (zh) * 2012-08-20 2014-02-05 深圳万和制药有限公司 一种复方聚乙二醇电解质组合物
PL3473248T3 (pl) 2012-09-11 2022-07-25 Norgine Bv Kompozycje zawierające glikol polietylenowy i siarczany metali alkalicznych lub metali ziem alkalicznych do zastosowania jako kompozycje do oczyszczania jelita grubego
US20140087007A1 (en) * 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations
KR20140044628A (ko) * 2012-10-05 2014-04-15 주식회사태준제약 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
KR101423005B1 (ko) 2013-10-17 2014-07-28 강윤식 장 세정용 조성물
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
KR102397379B1 (ko) 2014-03-25 2022-05-13 리딩 바이오사이언시즈, 인크. 자가소화의 치료용의 조성물
AU2015253178B2 (en) 2014-04-29 2020-03-12 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
US9907912B2 (en) * 2014-09-26 2018-03-06 John B. RANSOME Gelatin bowel prep with syringe for colonoscopy
CN104337834B (zh) * 2014-11-10 2017-06-30 河北爱能生物科技股份有限公司 一种羧甲基壳聚糖灌肠液
AU2016226380A1 (en) 2015-03-02 2017-09-21 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays
CN109310774A (zh) 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
FR3056109B1 (fr) 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
US11260064B2 (en) * 2018-01-11 2022-03-01 Viropharma Biologics Llc Stable corticosteroid compositions
KR20190093491A (ko) * 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
CN109223849A (zh) * 2018-08-10 2019-01-18 江汉大学 一种白菜冻干粉灌肠剂及其制备方法和应用
WO2020121994A1 (ja) * 2018-12-10 2020-06-18 日本製薬株式会社 医薬組成物
KR102217932B1 (ko) * 2019-03-21 2021-02-18 충남대학교산학협력단 비위관 삽입 보조기구
JP7011629B2 (ja) * 2019-07-11 2022-01-26 ノージン ビーブイ 結腸を洗浄する方法
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
US11793876B2 (en) * 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
PL243659B1 (pl) * 2020-10-30 2023-09-25 Biogliko Spolka Z Ograniczona Odpowiedzialnoscia Sucha kompozycja do rozpuszczania w wodzie
WO2022114970A1 (en) * 2020-11-24 2022-06-02 Industrial Innovation Center Antiviral food grade
US20240325436A1 (en) * 2021-06-17 2024-10-03 Braintree Laboratories, Inc. Safe Flavoring Composition to Improve Compliance in Colon Cleansing Compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211614A (en) 1963-07-10 1965-10-12 Pharmacia Ab Enema-type laxative composition
WO1987000754A1 (en) 1985-08-01 1987-02-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
EP0397689B1 (en) 1987-12-24 1994-05-11 BORODY, Thomas Julius Orthostatic lavage solutions
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
AU7786391A (en) * 1989-11-09 1991-06-13 Advanced Polymer Systems Inc. Methods and compositions for flavoring orally-delivered products
US5496535A (en) * 1991-04-12 1996-03-05 Alliance Pharmaceutical Corp. Fluorocarbon contrast media for use with MRI and radiographic imaging
RU2111741C1 (ru) 1994-10-27 1998-05-27 Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации Вещество для общего промывания желудочно-кишечного тракта
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
JP3119801B2 (ja) 1995-09-28 2000-12-25 武田薬品工業株式会社 ビタミン含有組成物の安定化方法
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JPH11228423A (ja) 1998-02-17 1999-08-24 Ohara Yakuhin Kogyo Kk 腸管洗浄液用組成物
US6048901A (en) 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
EP1443899B1 (en) * 2001-10-29 2010-08-18 Ajinomoto Co., Inc. Bowel cleansing agent
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
WO2005049049A1 (en) 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
ATE476180T1 (de) 2004-06-04 2010-08-15 Braintree Lab Verfahren zur darmreinigung

Also Published As

Publication number Publication date
RU2009105770A (ru) 2010-08-27
PL393711A1 (pl) 2011-05-23
DE03758361T1 (de) 2007-10-11
ES2285970T1 (es) 2007-12-01
PL374822A1 (en) 2005-10-31
AU2003274377A1 (en) 2004-05-13
AU2009227838A1 (en) 2009-11-05
AU2008100865B4 (en) 2008-11-20
SI1567193T1 (sl) 2008-12-31
MXPA05004347A (es) 2005-08-02
US20100297263A1 (en) 2010-11-25
JP2012025732A (ja) 2012-02-09
CA2502103C (en) 2009-04-07
JP5660320B2 (ja) 2015-01-28
RU2600790C2 (ru) 2016-10-27
AU2009227838B2 (en) 2013-08-15
CN101897721A (zh) 2010-12-01
ES2739387T3 (es) 2020-01-30
JP4784770B2 (ja) 2011-10-05
EP1567193B1 (en) 2008-08-13
TR201909741T4 (tr) 2019-07-22
US20100189815A1 (en) 2010-07-29
ES2285970T3 (es) 2009-02-01
AU2008100865A4 (en) 2008-10-09
HUE045881T2 (hu) 2020-01-28
EP2014304B1 (en) 2013-01-16
JP4131266B2 (ja) 2008-08-13
DK1567193T3 (da) 2008-12-01
ES2319093T1 (es) 2009-05-04
GB0224909D0 (en) 2002-12-04
DK2014304T3 (da) 2013-04-22
WO2004037292A1 (en) 2004-05-06
DE08014286T1 (de) 2009-06-04
SI2014304T1 (sl) 2013-05-31
RU2011144613A (ru) 2013-05-10
CN1705494A (zh) 2005-12-07
EP2014304B9 (en) 2013-04-17
DK2314319T3 (da) 2019-08-05
CA2502103A1 (en) 2004-05-06
EP1567193A1 (en) 2005-08-31
PT2314319T (pt) 2019-08-26
RU2353412C2 (ru) 2009-04-27
ZA200503247B (en) 2006-02-22
PT1567193E (pt) 2008-10-08
AU2003274377B2 (en) 2009-07-16
US20040143005A1 (en) 2004-07-22
SI2314319T1 (sl) 2019-08-30
EP2314319B1 (en) 2019-05-08
DE60322940D1 (de) 2008-09-25
US20100196513A1 (en) 2010-08-05
EP2314319A1 (en) 2011-04-27
PT2014304E (pt) 2013-04-02
RU2005116023A (ru) 2006-01-20
HK1077196A1 (en) 2006-02-10
CN1705494B (zh) 2010-11-10
JP2006507281A (ja) 2006-03-02
DE20321510U1 (de) 2007-09-20
ATE404223T1 (de) 2008-08-15
RU2600790C3 (ru) 2017-07-13
US20070098764A1 (en) 2007-05-03
EP2014304A1 (en) 2009-01-14
US7169381B2 (en) 2007-01-30
RU2519562C2 (ru) 2014-06-10
CN101897721B (zh) 2013-12-18
CY1113933T1 (el) 2016-07-27
JP2008001724A (ja) 2008-01-10
CA2672427A1 (en) 2004-05-06
US20070116667A1 (en) 2007-05-24
EP2014304A8 (en) 2009-03-11
RU2519562C9 (ru) 2014-08-20
PL220812B1 (pl) 2016-01-29
ES2319093T3 (es) 2013-05-09
PL216059B1 (pl) 2014-02-28
CY1121977T1 (el) 2020-10-14
CA2672427C (en) 2012-10-02
US20070086978A1 (en) 2007-04-19
US20100086624A1 (en) 2010-04-08
HK1126678A1 (en) 2009-09-11
US7658914B2 (en) 2010-02-09
LT2314319T (lt) 2019-09-10

Similar Documents

Publication Publication Date Title
CY1108505T1 (el) Σκευασματα κολικου καθαρισμου
NO20025819D0 (no) Natriumsalt og kontrastmiddel inneholdende dette
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
MX9205895A (es) Derivados de taxol solubles en agua.
CY1106055T1 (el) Τυποποιηση των υποκατεστημενων βενζιμιδαζολων
MX9701416A (es) Formulaciones de actividad superficial.
UY27320A1 (es) Nuevas composiciones farmacéuticas
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
CY1105060T1 (el) Νεες σουλφαμιδες και η χρηση τους σαν ανταγωνιστικων ληπτων ενδοθηλινης
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
EA200400962A1 (ru) Полиалкиленгликоль с остатком для конъюгации биологически активного соединения
NZ743984A (en) Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
AR117718A2 (es) Mejoramientos en composiciones farmacéuticas, y relacionados con ellas
ES2239576T3 (es) Composicion liquida de limpieza.
ATE413193T1 (de) Stabilisierte radiopharmazeutische zusammensetzungen
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
PT799046E (pt) Solucoes estaveis de 2-cloro-2'-desoxiadenosina
BR0110290A (pt) Preparação lìquida estabilizada
CY1108684T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων
IE44909B1 (en) Dental plaque disclosing agent
ATE477790T1 (de) Lösung zur darmreinigung
EA200101241A1 (ru) Производные индола
RU2010104395A (ru) Пероральные фармацевтические растворы, содержащие телбивудин
ES2358740T3 (es) Solución acuosa de olanexidina, procedimiento para su preparación y desinfectante.